Company Search:
Advanced Search
Sponsored Links
Repros Therapeutics Inc. Company Snapshot
Repros Therapeutics Inc. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Repros Therapeutics Inc. with three other pharmaceutical manufacturers in North America: Protokinetix, Inc. (2005 sales of $2,000.00 of which 100% was Medical Services), Aptose Biosciences Inc of Canada (6,000.00 Canadian Dollars [US$4,484.28 ] of which 100% was Cancer Therapies), and Arno Therapeutics, Inc. ($2,000.00 ).

Sales Analysis. Sales fell dramatically in 2005: During the year ended December of 2005, sales at Repros Therapeutics Inc. were $4,000.00 . This is a sharp decrease of 96.6% versus 2004, when the company's sales were $118,000.00 .
  Stock Performance Chart for Repros Therapeutics Inc.
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 1.16
(Figures in U.S. Dollars)
1 Week -7.2%   13 Weeks -2.5%  
4 Weeks -18.3%   52 Weeks 14.9%  
Repros Therapeutics Inc. Key Data:
  Ticker: RPRX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2005 Sales 4,000
(Year Ending Jan 2006).
Employees: 26
  Currency: U.S. Dollars Market Cap: 29,493,206
  Fiscal Yr Ends: December Shares Outstanding: 25,425,178
  Share Type: Common Closely Held Shares: 167,160
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.